OXIS INTERNATIONAL INC

New Filing
CIK: 0000109657·Other Health Care·DELAWARE·Filed: Jul 31, 2014
Total Offering

$1,425,000

Amount Sold

$1,425,000

Investors

11

First Sale

Jul 24, 2014

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Kenneth Eaton
Related Person
Anshuman Dube
Related Person
David Saloff
Related Person
Anthony Cataldo
Related Person

Company

GT Biopharma, Inc.

468 N. CAMDEN DR.

BEVERLY HILLS, CA, 90210

(310) 860-5184

SEC Filing

0001250853-14-000096

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free